Refine
Document Type
Is part of the Bibliography
- no (37)
Keywords
- Diagnose (11)
- Künstliche Intelligenz (11)
- Artificial Intelligence (9)
- Maschinelles Lernen (9)
- Speiseröhrenkrankheit (6)
- Speiseröhrenkrebs (6)
- Barrett's esophagus (5)
- Deep Learning (5)
- Machine learning (5)
- Adenocarcinoma (4)
Institute
- Fakultät Informatik und Mathematik (37) (remove)
Begutachtungsstatus
- peer-reviewed (31)
This work presents a systematic review concerning recent studies and technologies of machine learning for Barrett's esophagus (BE) diagnosis and treatment. The use of artificial intelligence is a brand new and promising way to evaluate such disease. We compile some works published at some well-established databases, such as Science Direct, IEEEXplore, PubMed, Plos One, Multidisciplinary Digital Publishing Institute (MDPI), Association for Computing Machinery (ACM), Springer, and Hindawi Publishing Corporation. Each selected work has been analyzed to present its objective, methodology, and results. The BE progression to dysplasia or adenocarcinoma shows a complex pattern to be detected during endoscopic surveillance. Therefore, it is valuable to assist its diagnosis and automatic identification using computer analysis. The evaluation of the BE dysplasia can be performed through manual or automated segmentation through machine learning techniques. Finally, in this survey, we reviewed recent studies focused on the automatic detection of the neoplastic region for classification purposes using machine learning methods.
The growing number of publications on the application of artificial intelligence (AI) in medicine underlines the enormous importance and potential of this emerging field of research.
In gastrointestinal endoscopy, AI has been applied to all segments of the gastrointestinal tract most importantly in the detection and characterization of colorectal polyps. However, AI research has been published also in the stomach and esophagus for both neoplastic and non-neoplastic disorders.
The various technical as well as medical aspects of AI, however, remain confusing especially for non-expert physicians.
This physician-engineer co-authored review explains the basic technical aspects of AI and provides a comprehensive overview of recent publications on AI in gastrointestinal endoscopy. Finally, a basic insight is offered into understanding publications on AI in gastrointestinal endoscopy.
Aims
Evaluation of the add-on effect an artificial intelligence (AI) based clinical decision support system has on the performance of endoscopists with different degrees of expertise in the field of Barrett's esophagus (BE) and Barrett's esophagus-related neoplasia (BERN).
Methods
The support system is based on a multi-task deep learning model trained to solve a segmentation and several classification tasks. The training approach represents an extension of the ECMT semi-supervised learning algorithm. The complete system evaluates a decision tree between estimated motion, classification, segmentation, and temporal constraints, to decide when and how the prediction is highlighted to the observer. In our current study, ninety-six video cases of patients with BE and BERN were prospectively collected and assessed by Barrett's specialists and non-specialists. All video cases were evaluated twice – with and without AI assistance. The order of appearance, either with or without AI support, was assigned randomly. Participants were asked to detect and characterize regions of dysplasia or early neoplasia within the video sequences.
Results
Standalone sensitivity, specificity, and accuracy of the AI system were 92.16%, 68.89%, and 81.25%, respectively. Mean sensitivity, specificity, and accuracy of expert endoscopists without AI support were 83,33%, 58,20%, and 71,48 %, respectively. Gastroenterologists without Barrett's expertise but with AI support had a comparable performance with a mean sensitivity, specificity, and accuracy of 76,63%, 65,35%, and 71,36%, respectively.
Conclusions
Non-Barrett's experts with AI support had a similar performance as experts in a video-based study.
Aims
While AI has been successfully implemented in detecting and characterizing colonic polyps, its role in therapeutic endoscopy remains to be elucidated. Especially third space endoscopy procedures like ESD and peroral endoscopic myotomy (POEM) pose a technical challenge and the risk of operator-dependent complications like intraprocedural bleeding and perforation. Therefore, we aimed at developing an AI-algorithm for intraprocedural real time vessel detection during ESD and POEM.
Methods
A training dataset consisting of 5470 annotated still images from 59 full-length videos (47 ESD, 12 POEM) and 179681 unlabeled images was used to train a DeepLabV3+neural network with the ECMT semi-supervised learning method. Evaluation for vessel detection rate (VDR) and time (VDT) of 19 endoscopists with and without AI-support was performed using a testing dataset of 101 standardized video clips with 200 predefined blood vessels. Endoscopists were stratified into trainees and experts in third space endoscopy.
Results
The AI algorithm had a mean VDR of 93.5% and a median VDT of 0.32 seconds. AI support was associated with a statistically significant increase in VDR from 54.9% to 73.0% and from 59.0% to 74.1% for trainees and experts, respectively. VDT significantly decreased from 7.21 sec to 5.09 sec for trainees and from 6.10 sec to 5.38 sec for experts in the AI-support group. False positive (FP) readings occurred in 4.5% of frames. FP structures were detected significantly shorter than true positives (0.71 sec vs. 5.99 sec).
Conclusions
AI improved VDR and VDT of trainees and experts in third space endoscopy and may reduce performance variability during training. Further research is needed to evaluate the clinical impact of this new technology.
Clinical setting
Third space procedures such as endoscopic submucosal dissection (ESD) and peroral endoscopic myotomy (POEM) are complex minimally invasive techniques with an elevated risk for operator-dependent adverse events such as bleeding and perforation. This risk arises from accidental dissection into the muscle layer or through submucosal blood vessels as the submucosal cutting plane within the expanding resection site is not always apparent. Deep learning algorithms have shown considerable potential for the detection and characterization of gastrointestinal lesions. So-called AI – clinical decision support solutions (AI-CDSS) are commercially available for polyp detection during colonoscopy. Until now, these computer programs have concentrated on diagnostics whereas an AI-CDSS for interventional endoscopy has not yet been introduced. We aimed to develop an AI-CDSS („Smart ESD“) for real-time intra-procedural detection and delineation of blood vessels, tissue structures and endoscopic instruments during third-space endoscopic procedures.
Characteristics of Smart ESD
An AI-CDSS was invented that delineates blood vessels, tissue structures and endoscopic instruments during third-space endoscopy in real-time. The output can be displayed by an overlay over the endoscopic image with different modes of visualization, such as a color-coded semitransparent area overlay, or border tracing (demonstration video). Hereby the optimal layer for dissection can be visualized, which is close above or directly at the muscle layer, depending on the applied technique (ESD or POEM). Furthermore, relevant blood vessels (thickness> 1mm) are delineated. Spatial proximity between the electrosurgical knife and a blood vessel triggers a warning signal. By this guidance system, inadvertent dissection through blood vessels could be averted.
Technical specifications
A DeepLabv3+ neural network architecture with KSAC and a 101-layer ResNeSt backbone was used for the development of Smart ESD. It was trained and validated with 2565 annotated still images from 27 full length third-space endoscopic videos. The annotation classes were blood vessel, submucosal layer, muscle layer, electrosurgical knife and endoscopic instrument shaft. A test on a separate data set yielded an intersection over union (IoU) of 68%, a Dice Score of 80% and a pixel accuracy of 87%, demonstrating a high overlap between expert and AI segmentation. Further experiments on standardized video clips showed a mean vessel detection rate (VDR) of 85% with values of 92%, 70% and 95% for POEM, rectal ESD and esophageal ESD respectively. False positive measurements occurred 0.75 times per minute. 7 out of 9 vessels which caused intraprocedural bleeding were caught by the algorithm, as well as both vessels which required hemostasis via hemostatic forceps.
Future perspectives
Smart ESD performed well for vessel and tissue detection and delineation on still images, as well as on video clips. During a live demonstration in the endoscopy suite, clinical applicability of the innovation was examined. The lag time for processing of the live endoscopic image was too short to be visually detectable for the interventionist. Even though the algorithm could not be applied during actual dissection by the interventionist, Smart ESD appeared readily deployable during visual assessment by ESD experts. Therefore, we plan to conduct a clinical trial in order to obtain CE-certification of the algorithm. This new technology may improve procedural safety and speed, as well as training of modern minimally invasive endoscopic resection techniques.
ARTIFICIAL INTELLIGENCE (AI) – ASSISTED VESSEL AND TISSUE RECOGNITION IN THIRD-SPACE ENDOSCOPY
(2022)
Aims
Third-space endoscopy procedures such as endoscopic submucosal dissection (ESD) and peroral endoscopic myotomy (POEM) are complex interventions with elevated risk of operator-dependent adverse events, such as intra-procedural bleeding and perforation. We aimed to design an artificial intelligence clinical decision support solution (AI-CDSS, “Smart ESD”) for the detection and delineation of vessels, tissue structures, and instruments during third-space endoscopy procedures.
Methods
Twelve full-length third-space endoscopy videos were extracted from the Augsburg University Hospital database. 1686 frames were annotated for the following categories: Submucosal layer, blood vessels, electrosurgical knife and endoscopic instrument. A DeepLabv3+neural network with a 101-layer ResNet backbone was trained and validated internally. Finally, the ability of the AI system to detect visible vessels during ESD and POEM was determined on 24 separate video clips of 7 to 46 seconds duration and showing 33 predefined vessels. These video clips were also assessed by an expert in third-space endoscopy.
Results
Smart ESD showed a vessel detection rate (VDR) of 93.94%, while an average of 1.87 false positive signals were recorded per minute. VDR of the expert endoscopist was 90.1% with no false positive findings. On the internal validation data set using still images, the AI system demonstrated an Intersection over Union (IoU), mean Dice score and pixel accuracy of 63.47%, 76.18% and 86.61%, respectively.
Conclusions
This is the first AI-CDSS aiming to mitigate operator-dependent limitations during third-space endoscopy. Further clinical trials are underway to better understand the role of AI in such procedures.
Aims
Endoscopic retrograde cholangiopancreaticography (ERCP) is the gold standard in the diagnosis as well as treatment of diseases of the pancreatobiliary tract. However, it is technically complex and has a relatively high complication rate. In particular, cannulation of the papillary ostium remains challenging. The aim of this study is to examine whether a deep-learning algorithm can be used to detect the major duodenal papilla and in particular the papillary ostium reliably and could therefore be a valuable tool for inexperienced endoscopists, particularly in training situation.
Methods
We analyzed a total of 654 retrospectively collected images of 85 patients. Both the major duodenal papilla and the ostium were then segmented. Afterwards, a neural network was trained using a deep-learning algorithm. A 5-fold cross-validation was performed. Subsequently, we ran the algorithm on 5 prospectively collected videos of ERCPs.
Results
5-fold cross-validation on the 654 labeled data resulted in an F1 value of 0.8007, a sensitivity of 0.8409 and a specificity of 0.9757 for the class papilla, and an F1 value of 0.5724, a sensitivity of 0.5456 and a specificity of 0.9966 for the class ostium. Regardless of the class, the average F1 value (class papilla and class ostium) was 0.6866, the sensitivity 0.6933 and the specificity 0.9861. In 100% of cases the AI-detected localization of the papillary ostium in the prospectively collected videos corresponded to the localization of the cannulation performed by the endoscopist.
Conclusions
In the present study, the neural network was able to identify the major duodenal papilla with a high sensitivity and high specificity. In detecting the papillary ostium, the sensitivity was notably lower. However, when used on videos, the AI was able to identify the location of the subsequent cannulation with 100% accuracy. In the future, the neural network will be trained with more data. Thus, a suitable tool for ERCP could be established, especially in the training situation.
Aims:
The delineation of outer margins of early Barrett's cancer can be challenging even for experienced endoscopists. Artificial intelligence (AI) could assist endoscopists faced with this task. As of date, there is very limited experience in this domain. In this study, we demonstrate the measure of overlap (Dice coefficient = D) between highly experienced Barrett endoscopists and an AI system in the delineation of cancer margins (segmentation task).
Methods:
An AI system with a deep convolutional neural network (CNN) was trained and tested on high-definition endoscopic images of early Barrett's cancer (n = 33) and normal Barrett's mucosa (n = 41). The reference standard for the segmentation task were the manual delineations of tumor margins by three highly experienced Barrett endoscopists. Training of the AI system included patch generation, patch augmentation and adjustment of the CNN weights. Then, the segmentation results from patch classification and thresholding of the class probabilities. Segmentation results were evaluated using the Dice coefficient (D).
Results:
The Dice coefficient (D) which can range between 0 (no overlap) and 1 (complete overlap) was computed only for images correctly classified by the AI-system as cancerous. At a threshold of t = 0.5, a mean value of D = 0.72 was computed.
Conclusions:
AI with CNN performed reasonably well in the segmentation of the tumor region in Barrett's cancer, at least when compared with expert Barrett's endoscopists. AI holds a lot of promise as a tool for better visualization of tumor margins but may need further improvement and enhancement especially in real-time settings.
Barrett's esophagus figured a swift rise in the number of cases in the past years. Although traditional diagnosis methods offered a vital role in early-stage treatment, they are generally time- and resource-consuming. In this context, computer-aided approaches for automatic diagnosis emerged in the literature since early detection is intrinsically related to remission probabilities. However, they still suffer from drawbacks because of the lack of available data for machine learning purposes, thus implying reduced recognition rates. This work introduces Generative Adversarial Networks to generate high-quality endoscopic images, thereby identifying Barrett's esophagus and adenocarcinoma more precisely. Further, Convolution Neural Networks are used for feature extraction and classification purposes. The proposed approach is validated over two datasets of endoscopic images, with the experiments conducted over the full and patch-split images. The application of Deep Convolutional Generative Adversarial Networks for the data augmentation step and LeNet-5 and AlexNet for the classification step allowed us to validate the proposed methodology over an extensive set of datasets (based on original and augmented sets), reaching results of 90% of accuracy for the patch-based approach and 85% for the image-based approach. Both results are based on augmented datasets and are statistically different from the ones obtained in the original datasets of the same kind. Moreover, the impact of data augmentation was evaluated in the context of image description and classification, and the results obtained using synthetic images outperformed the ones over the original datasets, as well as other recent approaches from the literature. Such results suggest promising insights related to the importance of proper data for the accurate classification concerning computer-assisted Barrett's esophagus and adenocarcinoma detection.
The number of patients with Barret’s esophagus (BE) has increased in the last decades. Considering the dangerousness of the disease and its evolution to adenocarcinoma, an early diagnosis of BE may provide a high probability of cancer remission. However, limitations regarding traditional methods of detection and management of BE demand alternative solutions. As such, computer-aided tools have been recently used to assist in this problem, but the challenge still persists. To manage the problem, we introduce the infinity Restricted Boltzmann Machines (iRBMs) to the task of automatic identification of Barrett’s esophagus from endoscopic images of the lower esophagus. Moreover, since iRBM requires a proper selection of its meta-parameters, we also present a discriminative iRBM fine-tuning using six meta-heuristic optimization techniques. We showed that iRBMs are suitable for the context since it provides competitive results, as well as the meta-heuristic techniques showed to be appropriate for such task.
In this work, we propose the use of single channel Color Co-occurrence Matrices for texture description of Barrett’sEsophagus (BE)and adenocarcinoma images. Further classification using supervised learning techniques, such as Optimum-Path Forest (OPF), Support Vector Machines with Radial Basisunction (SVM-RBF) and Bayesian classifier supports the contextof automatic BE and adenocarcinoma diagnosis. We validated three approaches of classification based on patches, patients and images in two datasets (MICCAI 2015 and Augsburg) using the color-and-texture descriptors and the machine learning techniques. Concerning MICCAI 2015 dataset, the best results were obtained using the blue channel for the descriptors and the supervised OPF for classification purposes in the patch-based approach, with sensitivity nearly to 73% for positive adenocarcinoma identification and specificity close to 77% for BE (non-cancerous) patch classification. Regarding the Augsburg dataset, the most accurate results were also obtained using both OPF classifier and blue channel descriptor for the feature extraction, with sensitivity close to 67% and specificity around to76%. Our work highlights new advances in the related research area and provides a promising technique that combines color and texture information, allied to three different approaches of dataset pre-processing aiming to configure robust scenarios for the classification step.
Barrett-Ampel
(2022)
Hintergrund
Adenokarzinome des Ösophagus sind bis heute mit einer infausten Prognose vergesellschaftet (1). Obwohl Endoskopiker mit Barrett-Ösophagus als Präkanzerose konfrontiert werden, ist vor allem für nicht-Experten die Differenzierung zwischen Barrett-Ösophagus ohne Dysplasie und assoziierten Neoplasien mitunter schwierig. Existierende Biopsieprotokolle (z.B. Seattle Protokoll) sind oftmals unzuverlässig (2). Eine frühzeitige Diagnose des Adenokarzinoms ist allerdings von fundamentaler Bedeutung für die Prognose des Patienten.
Forschungsansatz
Auf der Grundlage dieser Problematik, entwickelten wir in Kooperation mit dem Forschungslabor „Regensburg Medical Image Computing (ReMIC)“ der OTH Regensburg ein auf künstlicher Intelligenz (KI) basiertes Entscheidungsunterstützungssystem (CDSS). Das auf einer DeepLabv3+ neuronalen Netzwerkarchitektur basierende CDSS differenziert mittels Mustererkennung Barrett- Ösophagus ohne Dysplasie von Barrett-Ösophagus mit Dysplasie bzw. Neoplasie („Klassifizierung“). Hierbei werden gemittelte Ausgabewahrscheinlichkeiten mit einem vom Benutzer definierten Schwellenwert verglichen. Für Vorhersagen, die den Schwellenwert überschreiten, berechnen wir die Kontur der Region und die Fläche. Sobald die vorhergesagte Läsion eine bestimmte Größe in der Eingabe überschreitet, heben wir sie und ihren Umriss hervor. So ermöglicht eine farbkodierte Visualisierung eine Abgrenzung zwischen Dysplasie bzw. Neoplasie und normalem Barrett-Epithel („Segmentierung“).
In einer Studie an Bildern in „Weißlicht“ (WL) und „Narrow Band Imaging“ (NBI) demonstrierten wir eine Sensitivität von mehr als 90% und eine Spezifität von mehr als 80% (3). In einem nächsten Schritt, differenzierte unser KI-Algorithmus Barrett- Metaplasien von assoziierten Neoplasien anhand von zufällig abgegriffenen Bildern in Echtzeit mit einer Accuracy von 89.9% (4). Darauf folgend, entwickelten wir unser System dahingehend weiter, dass unser Algorithmus nun auch dazu in der Lage ist, Untersuchungsvideos in WL, NBI und „Texture and Color Enhancement Imaging“ (TXI) in Echtzeit zu analysieren (5).
Aktuell führen wir eine Studie in einem randomisiert-kontrollierten Ansatz an unveränderten Untersuchungsvideos in WL, NBI und TXI durch.
Ausblick
Um Patienten mit aus Barrett-Metaplasien resultierenden Neoplasien frühestmöglich an „High-Volume“-Zentren überweisen zu können, soll unser KI-Algorithmus zukünftig vor allem Endoskopiker ohne extensive Erfahrung bei der Beurteilung von Barrett- Ösophagus in der Krebsfrüherkennung unterstützen.
We propose an automatic approach for early detection of adenocarcinoma in the esophagus. High-definition endoscopic images (50 cancer, 50 Barrett) are partitioned into a dataset containing approximately equal amounts of patches showing cancerous and non-cancerous regions. A deep convolutional neural network is adapted to the data using a transfer learning approach. The final classification of an image is determined by at least one patch, for which the probability being a cancer patch exceeds a given threshold. The model was evaluated with leave one patient out cross-validation. With sensitivity and specificity of 0.94 and 0.88, respectively, our findings improve recently published results on the same image data base considerably. Furthermore, the visualization of the class probabilities of each individual patch indicates, that our approach might be extensible to the segmentation domain.
Computer-aided diagnosis using deep learning in the evaluation of early oesophageal adenocarcinoma
(2019)
Computer-aided diagnosis using deep learning (CAD-DL) may be an instrument to improve endoscopic assessment of Barrett’s oesophagus
(BE) and early oesophageal adenocarcinoma (EAC). Based on still images from two databases, the diagnosis of EAC by CAD-DL reached sensitivities/specificities of 97%/88% (Augsburg data) and 92%/100% (Medical Image Computing and Computer-Assisted Intervention [MICCAI]
data) for white light (WL) images and 94%/80% for narrow band images (NBI) (Augsburg data), respectively. Tumour margins delineated by
experts into images were detected satisfactorily with a Dice coefficient (D) of 0.72. This could be a first step towards CAD-DL for BE assessment. If developed further, it could become a useful
adjunctive tool for patient management.
Even though artificial intelligence and machine learning have demonstrated remarkable performances in medical image computing, their level of accountability and transparency must be provided in such evaluations. The reliability related to machine learning predictions must be explained and interpreted, especially if diagnosis support is addressed. For this task, the black-box nature of deep learning techniques must be lightened up to transfer its promising results into clinical practice. Hence, we aim to investigate the use of explainable artificial intelligence techniques to quantitatively highlight discriminative regions during the classification of earlycancerous tissues in Barrett’s esophagus-diagnosed patients. Four Convolutional Neural Network models (AlexNet, SqueezeNet, ResNet50, and VGG16) were analyzed using five different interpretation techniques (saliency, guided backpropagation, integrated gradients, input × gradients, and DeepLIFT) to compare their agreement with experts’ previous annotations of cancerous tissue. We could show that saliency attributes match best with the manual experts’ delineations. Moreover, there is moderate to high correlation between the sensitivity of a model and the human-and-computer agreement. The results also lightened that the higher the model’s sensitivity, the stronger the correlation of human and computational segmentation agreement. We observed a relevant relation between computational learning and experts’ insights, demonstrating how human knowledge may influence the correct computational learning.
Limitations in computer-assisted diagnosis include lack of labeled data and inability to model the relation between what experts see and what computers learn. Even though artificial intelligence and machine learning have demonstrated remarkable performances in medical image computing, their accountability and transparency level must be improved to transfer this success into clinical practice. The reliability of machine learning decisions must be explained and interpreted, especially for supporting the medical diagnosis. While deep learning techniques are broad so that unseen information might help learn patterns of interest, human insights to describe objects of interest help in decision-making. This paper proposes a novel approach, DeepCraftFuse, to address the challenge of combining information provided by deep networks with visual-based features to significantly enhance the correct identification of cancerous tissues in patients affected with Barrett’s esophagus (BE). We demonstrate that DeepCraftFuse outperforms state-of-the-art techniques on private and public datasets, reaching results of around 95% when distinguishing patients affected by BE that is either positive or negative to esophageal cancer.
Background and aims
Celiac disease with its endoscopic manifestation of villous atrophy is underdiagnosed worldwide. The application of artificial intelligence (AI) for the macroscopic detection of villous atrophy at routine esophagogastroduodenoscopy may improve diagnostic performance.
Methods
A dataset of 858 endoscopic images of 182 patients with villous atrophy and 846 images from 323 patients with normal duodenal mucosa was collected and used to train a ResNet 18 deep learning model to detect villous atrophy. An external data set was used to test the algorithm, in addition to six fellows and four board certified gastroenterologists. Fellows could consult the AI algorithm’s result during the test. From their consultation distribution, a stratification of test images into “easy” and “difficult” was performed and used for classified performance measurement.
Results
External validation of the AI algorithm yielded values of 90 %, 76 %, and 84 % for sensitivity, specificity, and accuracy, respectively. Fellows scored values of 63 %, 72 % and 67 %, while the corresponding values in experts were 72 %, 69 % and 71 %, respectively. AI consultation significantly improved all trainee performance statistics. While fellows and experts showed significantly lower performance for “difficult” images, the performance of the AI algorithm was stable.
Conclusion
In this study, an AI algorithm outperformed endoscopy fellows and experts in the detection of villous atrophy on endoscopic still images. AI decision support significantly improved the performance of non-expert endoscopists. The stable performance on “difficult” images suggests a further positive add-on effect in challenging cases.
Aims
Artificial Intelligence (AI) systems in gastrointestinal endoscopy are narrow because they are trained to solve only one specific task. Unlike Narrow-AI, general AI systems may be able to solve multiple and unrelated tasks. We aimed to understand whether an AI system trained to detect, characterize, and segment early Barrett’s neoplasia (Barrett’s AI) is only capable of detecting this pathology or can also detect and segment other diseases like early squamous cell cancer (SCC).
Methods
120 white light (WL) and narrow-band endoscopic images (NBI) from 60 patients (1 WL and 1 NBI image per patient) were extracted from the endoscopic database of the University Hospital Augsburg. Images were annotated by three expert endoscopists with extensive experience in the diagnosis and endoscopic resection of early esophageal neoplasias. An AI system based on DeepLabV3+architecture dedicated to early Barrett’s neoplasia was tested on these images. The AI system was neither trained with SCC images nor had it seen the test images prior to evaluation. The overlap between the three expert annotations („expert-agreement“) was the ground truth for evaluating AI performance.
Results
Barrett’s AI detected early SCC with a mean intersection over reference (IoR) of 92% when at least 1 pixel of the AI prediction overlapped with the expert-agreement. When the threshold was increased to 5%, 10%, and 20% overlap with the expert-agreement, the IoR was 88%, 85% and 82%, respectively. The mean Intersection Over Union (IoU) – a metric according to segmentation quality between the AI prediction and the expert-agreement – was 0.45. The mean expert IoU as a measure of agreement between the three experts was 0.60.
Conclusions
In the context of this pilot study, the predictions of SCC by a Barrett’s dedicated AI showed some overlap to the expert-agreement. Therefore, features learned from Barrett’s cancer-related training might be helpful also for SCC prediction. Our results allow different possible explanations. On the one hand, some Barrett’s cancer features generalize toward the related task of assessing early SCC. On the other hand, the Barrett’s AI is less specific to Barrett’s cancer than a general predictor of pathological tissue. However, we expect to enhance the detection quality significantly by extending the training to SCC-specific data. The insight of this study opens the way towards a transfer learning approach for more efficient training of AI to solve tasks in other domains.
Effect of AI on performance of endoscopists to detect Barrett neoplasia: A Randomized Tandem Trial
()
Background and study aims
To evaluate the effect of an AI-based clinical decision support system (AI) on the performance and diagnostic confidence of endoscopists during the assessment of Barrett's esophagus (BE).
Patients and Methods
Ninety-six standardized endoscopy videos were assessed by 22 endoscopists from 12 different centers with varying degrees of BE experience.
The assessment was randomized into two video sets: Group A (review first without AI and second with AI) and group B (review first with AI and second without AI). Endoscopists were required to evaluate each video for the presence of Barrett's esophagus-related neoplasia (BERN) and then decide on a spot for a targeted biopsy. After the second assessment, they were allowed to change their clinical decision and confidence level.
Results
AI had a standalone sensitivity, specificity, and accuracy of 92.2%, 68.9%, and 81.6%, respectively. Without AI, BE experts had an overall sensitivity, specificity, and accuracy of 83.3%, 58.1 and 71.5%, respectively. With AI, BE nonexperts showed a significant improvement in sensitivity and specificity when videos were assessed a second time with AI (sensitivity 69.7% (95% CI, 65.2% - 74.2%) to 78.0% (95% CI, 74.0% - 82.0%); specificity 67.3% (95% CI, 62.5% - 72.2%) to 72.7% (95 CI, 68.2% - 77.3%). In addition, the diagnostic confidence of BE nonexperts improved significantly with AI.
Conclusion
BE nonexperts benefitted significantly from the additional AI. BE experts and nonexperts remained below the standalone performance of AI, suggesting that there may be other factors influencing endoscopists to follow or discard AI advice.
Einleitung
Third space Endoskopieprozeduren wie die endoskopische Submukosadissektion (ESD) und die perorale endoskopische Myotomie (POEM) sind technisch anspruchsvoll und gehen mit untersucherabhängigen Komplikationen wie Blutungen und Perforationen einher. Grund hierfür ist die unabsichtliche Durchschneidung von submukosalen Blutgefäßen ohne präemptive Koagulation.
Ziele
Die Forschungsfrage, ob ein KI-Algorithmus die intraprozedurale Gefäßerkennung bei ESD und POEM unterstützen und damit Komplikationen wie Blutungen verhindern könnte, erscheint in Anbetracht des erfolgreichen Einsatzes von KI bei der Erkennung von Kolonpolypen interessant.
Methoden
Auf 5470 Einzelbildern von 59 third space Endoscopievideos wurden submukosale Blutgefäße annotiert. Zusammen mit weiteren 179.681 nicht-annotierten Bildern wurde ein DeepLabv3+neuronales Netzwerk mit dem ECMT-Verfahren für semi-supervised learning trainiert, um Blutgefäße in Echtzeit erkennen zu können. Für die Evaluation wurde ein Videotest mit 101 Videoclips aus 15 vom Trainingsdatensatz separaten Prozeduren mit 200 vordefinierten Gefäßen erstellt. Die Gefäßdetektionsrate, -zeit und -dauer, definiert als der Prozentsatz an Einzelbildern eines Videos bezogen auf den Goldstandard, auf denen ein definiertes Gefäß erkannt wurde, wurden erhoben. Acht erfahrene Endoskopiker wurden mithilfe dieses Videotests im Hinblick auf Gefäßdetektion getestet, wobei eine Hälfte der Videos nativ, die andere Hälfte nach Markierung durch den KI-Algorithmus angesehen wurde.
Ergebnisse
Der mittlere Dice Score des Algorithmus für Blutgefäße war 68%. Die mittlere Gefäßdetektionsrate im Videotest lag bei 94% (96% für ESD; 74% für POEM). Die mediane Gefäßdetektionszeit des Algorithmus lag bei 0,32 Sekunden (0,3 Sekunden für ESD; 0,62 Sekunden für POEM). Die mittlere Gefäßdetektionsdauer lag bei 59,1% (60,6% für ESD; 44,8% für POEM) des Goldstandards. Alle Endoskopiker hatten mit KI-Unterstützung eine höhere Gefäßdetektionsrate als ohne KI. Die mittlere Gefäßdetektionsrate ohne KI lag bei 56,4%, mit KI bei 71,2% (p<0.001).
Schlussfolgerung
KI-Unterstützung war mit einer statistisch signifikant höheren Gefäßdetektionsrate vergesellschaftet. Die mediane Gefäßdetektionszeit von deutlich unter einer Sekunde sowie eine Gefäßdetektionsdauer von größer 50% des Goldstandards wurden für den klinischen Einsatz als ausreichend erachtet. In prospektiven Anwendungsstudien sollte der KI-Algorithmus auf klinische Relevanz getestet werden.